Aisa-Alvarez Alfredo, Soto María Elena, Guarner-Lans Verónica, Camarena-Alejo Gilberto, Franco-Granillo Juvenal, Martínez-Rodríguez Enrique A, Gamboa Ávila Ricardo, Manzano Pech Linaloe, Pérez-Torres Israel
Critical Care Department, American British Cowdray (ABC) Medical Center, I.A.P. ABC Sur 136 No. 116 Col. las Américas, Mexico City 01120, Mexico.
Immunology Department Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, Tlalpan, Mexico City 14080, Mexico.
Medicina (Kaunas). 2020 Nov 17;56(11):619. doi: 10.3390/medicina56110619.
Oxidative stress (OS) participates in the pathophysiology of septic shock, which leads to multiple organ failure (MOF), ischemia-reperfusion injury, and acute respiratory distress syndrome. Therefore, antioxidants have been proposed as therapy. Here, we evaluated the effect of antioxidant treatments in patients with septic shock with MOF and determined levels OS before and after treatment. This study was a randomized, controlled, triple-masked, and with parallel assignment clinical trial with a control group without treatment. It included 97 patients of either sex with septic shock. 5 treatments were used each in an independent group of 18 patients. Group 1 received vitamin C (Vit C), group 2 vitamin E (Vit E), group 3 n-acetylcysteine (NAC), group 4 melatonin (MT), and group 5 served as control. All antioxidants were administered orally or through a nasogastric tube for five days as an adjuvant to the standard therapy. The results showed that all patients presented MOF due to sepsis upon admission and that the treatment decreased it ( = 0.007). The antioxidant treatment with NAC increased the total antioxidant capacity ( < 0.05). The patients that received Vit C had decreased levels of the nitrate and nitrite ratio ( < 0.01) and C-reactive protein levels ( = 0.04). Procalcitonin levels were reduced by Vit E ( = 0.04), NAC ( = 0.001), and MT ( = 0.04). Lipid-peroxidation was reduced in patients that received MT ( = 0.04). In conclusion, antioxidant therapy associated with standard therapy reduces MOF, OS, and inflammation in patients with septic shock.
氧化应激(OS)参与脓毒性休克的病理生理学过程,可导致多器官功能衰竭(MOF)、缺血-再灌注损伤和急性呼吸窘迫综合征。因此,抗氧化剂已被提议作为治疗手段。在此,我们评估了抗氧化剂治疗对伴有MOF的脓毒性休克患者的疗效,并测定了治疗前后的OS水平。本研究是一项随机、对照、三盲且平行分组的临床试验,设有未接受治疗的对照组。研究纳入了97例患有脓毒性休克的患者,男女不限。18例患者为一组,共设置了5种治疗方案。第1组接受维生素C(Vit C)治疗,第2组接受维生素E(Vit E)治疗,第3组接受N-乙酰半胱氨酸(NAC)治疗,第4组接受褪黑素(MT)治疗,第5组作为对照组。所有抗氧化剂均口服或通过鼻胃管给药,持续5天,作为标准治疗的辅助治疗。结果显示,所有患者入院时均因脓毒症出现MOF,且治疗后MOF有所减轻(P = 0.007)。NAC抗氧化治疗可提高总抗氧化能力(P < 0.05)。接受Vit C治疗的患者,其硝酸盐与亚硝酸盐比值水平降低(P < 0.01),C反应蛋白水平降低(P = 0.04)。Vit E(P = 0.04)、NAC(P = 0.001)和MT(P = 0.04)均可降低降钙素原水平。接受MT治疗的患者脂质过氧化水平降低(P = 0.04)。总之,与标准治疗联合使用的抗氧化剂疗法可减轻脓毒性休克患者的MOF、OS和炎症反应。